"False"
Hoppa direkt till innehållet
umu.se
För studenter
Bibliotek
För medarbetare
Logga in
Student
Alla studenter måste byta lösenord efter 7 maj.
Redigera
Redigera innehåll på umu.se
English site
Sök
Meny
X stäng menyn
Meny
Sök
Sök inom:
Sök inom:
Allt
Utbildning
Forskning
Personal
Studentwebb
Nyheter
Andra söktjänster
Hitta kurser och program
Sök kursplan
Sök välkomstbrev
Bibliotekets söktjänst
Sök i regelverket
Huvudmenyn dold.
Logga in
Student
Alla studenter måste byta lösenord efter 7 maj.
Redigera
Redigera innehåll på umu.se
English
Anne Andersson
Kontakt
E-post
anne.andersson@umu.se
Telefon
090-785 78 87
Verksam vid
Anknytning
Anknuten som läkare till
Institutionen för diagnostik och intervention
Enhet: Onkologi
Plats
27C, Målpunkt QC31, Norrlands universitetssjukhus
Umeå universitet, 901 85 Umeå
Publikationer
Publikationer
Forskning
Forskning
2024
Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences
Acta Oncologica
, Uppsala: MJS Publishing, Medical Journals Sweden AB 2024, Vol. 63 : 901-908
De Jong, Anna; Von Wachenfeldt, Anna; Nyström, Lennarth; et al.
2024
Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40-74 years at diagnosis in Sweden 2008-2017
Acta Oncologica
, Medical Journals Sweden 2024, Vol. 63 : 552-556
Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.
2024
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 2017
Journal of Medical Screening
, Sage Publications 2024, Vol. 31, (4) : 248-257
Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.
2024
Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: end-of-study results of the randomized PANTHER trial
Journal of Clinical Oncology
, American Society of Clinical Oncology (ASCO) 2024, Vol. 42, (26) : 3077-3082
Matikas, Alexios; Möbus, Volker; Greil, Richard; et al.
2024
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the swedish phase ii randomized predix HER2 trial
Breast Cancer Research and Treatment
, Springer 2024, Vol. 204, (2) : 299-308
Zhu, Yajing; Zerdes, Ioannis; Matikas, Alexios; et al.
2023
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
Free Radical Biology & Medicine
, Elsevier 2023, Vol. 209 : 381-393
Hughes, David J.; Schomburg, Lutz; Jenab, Mazda; et al.
2023
Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
Breast Cancer Research and Treatment
, Springer Nature 2023, Vol. 198, (2) : 361-368
Sund, Maria; Garmo, Hans; Andersson, Anne; et al.
2023
Receptor conversion and survival in breast cancer liver metastases
Breast Cancer Research
, BioMed Central (BMC) 2023, Vol. 25, (1)
Sundén, Marcus; Norgren, Sofia; Lundqvist, Robert; et al.
2021
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma: is there a need for intervention in long-term survivors?
Upsala Journal of Medical Sciences
, Upsala Medical Society 2021, Vol. 126
Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; et al.
2021
Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer
JAMA Oncology
, American Medical Association (AMA) 2021, Vol. 7, (9) : 1360-1367
Hatschek, Thomas; Foukakis, Theodoros; Bjöhle, Judith; et al.
2020
Surgical treatment of breast cancer liver metastases: A nationwide registry-based case control study
European Journal of Surgical Oncology
, Elsevier 2020, Vol. 46, (6) : 1006-1012
Sundén, Marcus; Hermansson, Cecilia; Taflin, Helena; et al.
2019
Adherence to adjuvant endocrine therapy after breast cancer in Sweden 2008-2010: a nationwide survey
American Society of Clinical Oncology 2019
Andersson, Anne; von Wachenfeldt Väppling, Anna; de Jong, Anna; et al.
2019
Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?
Journal of Clinical Oncology
, American Society of Clinical Oncology 2019, Vol. 37, (15) : 501-501
Bergh, Jonas C. S.; Andersson, Anne; Bjohle, Judith; et al.
2019
Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer.
Journal of Clinical Oncology
, American Society of Clinical Oncology 2019, Vol. 37, (15) : 583-583
Brandberg, Yvonne; Andersson, Anne; Bjohle, Judith; et al.
2017
Biverkningar vid antihormonell behandling påverkar följsamhet: Viktigt vara medveten om problemen för att motivera patienter att fullfölja behandlingen
Läkartidningen
, Läkartidningen Förlag 2017, Vol. 114, (7)
von Wachenfeldt, Anna; Andersson, Anne; Fornander, Tommy; et al.
2015
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: a nested case-control study
PLOS ONE
, PLOS one 2015, Vol. 10, (10)
Clendenen, Tess V.; Ge, Wenzhen; Koenig, Karen L.; et al.
2015
Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study
International Journal of Cancer
, Vol. 136, (11) : 2640-2648
McKenzie, Fiona; Ferrari, Pietro; Freisling, Heinz; et al.
2015
Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)
International Journal of Cancer
, Vol. 137, (4) : 940-948
Ricceri, Fulvio; Fasanelli, Francesca; Giraudo, Maria Teresa; et al.
2015
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study
Breast Cancer Research
, Vol. 17
Tikk, Kaja; Sookthai, Disorn; Fortner, Renee T.; et al.
2014
Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases
Cancer Epidemiology, Biomarkers and Prevention
, Vol. 23, (6) : 934-945
Ali, Alaa M. G.; Schmidt, Marjanka K.; Bolla, Manjeet K.; et al.
2014
Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study
International Journal of Cancer
, Vol. 135, (12) : 2887-2899
Emaus, Marleen J.; van Gils, Carla H.; Bakker, Marije F.; et al.
2014
Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status: A prospective study within the EPIC cohort
International Journal of Cancer
, Vol. 134, (11) : 2683-2690
Kaaks, Rudolf; Johnson, Theron; Tikk, Kaja; et al.
2014
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort
International Journal of Cancer
, Vol. 134, (8) : 1947-1957
Kaaks, Rudolf; Tikk, Kaja; Sookthai, Disorn; et al.
2014
Dietary fat intake and development of specific breast cancer subtypes
Journal of the National Cancer Institute
, Oxford University Press 2014, Vol. 106, (5) : dju068-
Sieri, Sabina; Chiodini, Paolo; Agnoli, Claudia; et al.
2014
Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort
Annals of Oncology
, Oxford University Press 2014, Vol. 25, (7) : 1422-1428
Tikk, Kaja; Sookthai, Disorn; Johnson, Theron; et al.
2013
Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case-control study
International Journal of Cancer
, Vol. 133, (7) : 1689-1700
Kühn, Tilman; Kaaks, Rudolf; Becker, Susen; et al.
2013
Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study
International Journal of Cancer
, Wiley-Blackwell 2013, Vol. 132, (11) : 2619-2629
Ritte, Rebecca; Lukanova, Annekatrin; Tjonneland, Anne; et al.
2013
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study
BMC Cancer
, BioMed Central 2013, Vol. 13 : Article Number: 584-
Ritte, Rebecca; Tikk, Kaja; Lukanova, Annekatrin; et al.
2013
Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition
International Journal of Cancer
, Vol. 132, (7) : 1667-1678
Steindorf, Karen; Ritte, Rebecca; Eomois, Piia-Piret; et al.
2011
Long-term side effects after treatment of Hodgkin's lymphoma
Umeå University medical dissertations
, 1416
Andersson, Anne
2011
Long term risk of infections in Hodgkin lymphoma long-term survivors
British Journal of Haematology
, Vol. 154, (5) : 661-663
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
2009
Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors: retrospective cohort analyses and a concept for prospective intervention
International Journal of Cancer
, Vol. 124, (8) : 1914-1917
Andersson, Anne; Näslund, Ulf; Tavelin, Björn; et al.
2008
Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
British Journal of Cancer
, Vol. 98, (5) : 1001-1005
Andersson, Anne; Enblad, Gunilla; Tavelin, Björn; et al.
Cardiovascular side effects following treatment of Hodgkin’s lymphoma: comorbidity factors and a strategy for intervention
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
Visa publikationer i DiVA
Forskargrupper
Gruppmedlem
Håkan Jonsson lab
Forskningsprojekt
1 december 2023 till 31 december 2028
Biomarkörer för tidig upptäckt av bröstcancer
+ Visa mer
- Visa mindre